Clinical Trial Update: Study Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 Days [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing Telithromycin once daily for 7 days versus Azithromycin once daily for 5 days in outpatients with mild to moderate community-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Ketek (telithromycin)
• ZITHROMAX (AZITHROMYCIN DIHYDRATE)

Snippet

Sponsor: Sanofi | Conditions: Pneumonia | Phase 4 | Status: TERMINATED